Phantoms for spectral CT experiments
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring phantoms for spectral CT experiments, with solicitation release estimated for May 1, 2027 and award targeted for September 1, 2027. Each phantom features cylindrical geometry with iodine and calcium hydroxyapatite inserts embedded in uniform background materials, designed for spectral CT experimentation. This is a new requirement with no set-aside applied.
The estimated award value ranges from $10,000 to $25,000. Inquiries should be directed to the FDA's acquisition mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
BPID: 908 - Phantoms for spectral CT experiments each phantom has a cylindrical geometry with iodine and CaHA inserts with uniform background materials. The phantoms are for spectral CT experimentation.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast